Clinical Trial Update: Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update concerns the safety and efficacy of intracoronary Ad5FGF-4 in patients with stable angina across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina

Drugs mentioned

• Ad5FGF-4 (adenovirus type 5 fibroblast growth factor-4 gene therapy)

Snippet

Sponsor: Cardium Therapeutics | Conditions: Stable Angina | Phase 2, Phase 3 | Status: UNKNOWN